David Matthew T. - 01 Nov 2021 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
Interim CEO and CFO
Signature
/s/ Matthew T. David
Issuer symbol
CRMD
Transactions as of
01 Nov 2021
Net transactions value
$0
Form type
4
Filing time
10 Nov 2021, 16:24:29 UTC
Next filing
19 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CRMD Common Stock 1,150 01 Nov 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRMD Stock Option (Right to Buy Common Stock) Award $0 +125,000 $0.000000 125,000 01 Nov 2021 Common Stock 125,000 $5.56 Direct F1
holding CRMD Stock Option (Right to Buy Common Stock) 80,000 01 Nov 2021 Common Stock 80,000 $8.32 Direct F2
holding CRMD Stock Option (Right to Buy Common Stock) 125,000 01 Nov 2021 Common Stock 125,000 $5.63 Direct F3
holding CRMD Stock Option (Right to Buy Common Stock) 125,000 01 Nov 2021 Common Stock 125,000 $4.08 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted on 11/1/2021. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
F2 These options were granted on 1/11/2021. These options vest, subject to continued employment, as follows: 50% of the options vest over time, with 25% vested on the grant date and 25% vesting in equal thirds on the first, second and third anniversaries of the grant date; and 50% of the options vest upon the achievement of certain milestones.
F3 These options were granted on 05/11/2020. 83,000 of these options vest annually over four years in four equal installments beginning 05/11/2021, subject to continued employment, and 42,000 of these options vest based on achievement of certain performance milestones, subject to continued employment through the applicable vesting date.